Colchicine and the heart: Pushing the envelope

Journal of the American College of Cardiology

Volumn 62, Issue 20, 2013, Pages 1817-1825

  Deftereos, Spyridon ^a,b   Giannopoulos, Georgios ^a   Papoutsidakis, Nikolaos ^a   Panagopoulou, Vasiliki ^a   Kossyvakis, Charalampos ^a   Raisakis, Konstantinos ^a   Cleman, Michael W ^b   Stefanadis, Christodoulos ^c  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

atrial fibrillation; cardiac disease; colchicine; coronary artery disease; pharmacology

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; ENALAPRIL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE;

ABLATION THERAPY; ACUTE CORONARY SYNDROME; ADJUVANT THERAPY; ANTIINFLAMMATORY ACTIVITY; APLASTIC ANEMIA; BARE METAL STENT; BONE MARROW DEPRESSION; BRAIN ISCHEMIA; CHEMOPROPHYLAXIS; CORONARY ARTERY DISEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG ELUTING STENT; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL SYMPTOM; GOUT; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LEUKOPENIA; LIVER FAILURE; LOADING DRUG DOSE; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PERICARDITIS; POSTPERICARDIOTOMY SYNDROME; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RHABDOMYOLYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSPECIFIED SIDE EFFECT;

ACS; ACUTE CORONARY SYNDROME(S); AF; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CAD; CARDIAC DISEASE; COLCHICINE; CORONARY ARTERY DISEASE; CRP; IL; INTERLEUKIN; NONSTEROIDAL ANTI-INFLAMMATORY DRUG; NSAID; PCI; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOLOGY; POAF; POST-OPERATIVE ATRIAL FIBRILLATION;

ANGIOPLASTY; ANIMALS; ATRIAL FIBRILLATION; COLCHICINE; CORONARY ARTERY DISEASE; HEART DISEASES; HUMANS; PERICARDITIS; TUBULIN MODULATORS;

EID: 84887174474     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.726     Document Type: Review

References (88)

1. G. Nuki, and P.A. Simkin A concise history of gout and hyperuricemia and their treatment Arthritis Res Ther 8 Suppl 1 2006 S1
2. P.J. Pelletier, and J.B. Caventou Examen chimique des plusieurs végétaux de la famille des colchicées, et du principe actif qu'ils renferment. [Cévadille (veratrum sabadilla); hellébore blanc (veratrum album); colchique commun (colchicum autumnale)] Annales de Chimie et de Physique 14 1820 69 81
3. J. Woodcock, and S. Okada Incentives for drug development-the curious case of colchicine N Engl J Med 363 2010 1484 author reply 1484-5
4. M. Imazio Contemporary management of pericardial diseases Curr Opin Cardiol 27 2012 308 317
5. G.M. Ferron, M. Rochdi, W.J. Jusko, and J.M. Scherrmann Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses J Clin Pharmacol 36 1996 874 883
6. A. Sabouraud, O. Chappey, T. Dupin, and J.M. Scherrmann Binding of colchicine and thiocolchicoside to human serum proteins and blood cells Int J Clin Pharmacol Ther 32 1994 429 432
7. O.N. Chappey, E. Niel, and J.L. Wautier Colchicine disposition in human leukocytes after single and multiple oral administration Clin Pharmacol Ther 54 1993 360 367
8. R.A. Terkeltaub Colchicine update: 2008 Semin Arthritis Rheum 38 2009 411 419
9. M. Rochdi, A. Sabouraud, C. Girre, R. Venet, and J.M. Scherrmann Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects Eur J Clin Pharmacol 46 1994 351 354
10. C. Putterman, E. Ben-Chetrit, Y. Caraco, and M. Levy Colchicine intoxication: clinical pharmacology, risk factors, features, and management Semin Arthritis Rheum 21 1991 143 155
11. B. Bhattacharyya, D. Panda, S. Gupta, and M. Banerjee Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin Med Res Rev 28 2008 155 183
12. B.N. Cronstein, Y. Molad, J. Reibman, E. Balakhane, R.I. Levin, and G. Weissmann Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils J Clin Invest 96 1995 994 1002
13. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
14. T. Misawa, M. Takahama, and T. Kozaki Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome Nat Immunol 14 2013 454 460
15. F. Zheng, S. Xing, Z. Gong, and Q. Xing NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis Heart Lung Circ 22 2013 746 750
16. M. Kawaguchi, M. Takahashi, and T. Hata Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury Circulation 123 2011 594 604
17. E. Ben-Chetrit, S. Bergmann, and R. Sood Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis Rheumatology (Oxford) 45 2006 274 282
18. S. Preau, D. Montaigne, and T. Modine Macrophage migration inhibitory factor induces contractile and mitochondria dysfunction by altering cytoskeleton network in the human heart Crit Care Med 41 2013 e125 e133
19. Y. Adler, Y. Finkelstein, and J. Guindo Colchicine treatment for recurrent pericarditis. A decade of experience Circulation 97 1998 2183 2185
20. B. Maisch, P.M. Seferovic, and A.D. Ristic Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology Eur Heart J 25 2004 587 610
21. M. Imazio, M. Bobbio, and E. Cecchi Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial Circulation 112 2005 2012 2016
22. M. Imazio, M. Bobbio, and E. Cecchi Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial Arch Intern Med 165 2005 1987 1991
23. M. Imazio, A. Brucato, and R. Cemin Colchicine for recurrent pericarditis (CORP): a randomized trial Ann Intern Med 155 2011 409 414
24. L.S. Lilly Treatment of acute and recurrent idiopathic pericarditis Circulation 127 2013 1723 1726
25. M. Imazio Evaluation and management of pericarditis Expert Rev Cardiovasc Ther 9 2011 1221 1233
26. W.H. Maisel, J.D. Rawn, and W.G. Stevenson Atrial fibrillation after cardiac surgery Ann Intern Med 135 2001 1061 1073
27. A. Saxena, D.T. Dinh, J.A. Smith, G.C. Shardey, C.M. Reid, and A.E. Newcomb Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients) Am J Cardiol 109 2012 219 225
28. C.W. Hogue Jr., L.L. Creswell, D.D. Gutterman, and L.A. Fleisher Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 9S 16S
29. M. Imazio, A. Brucato, and P. Ferrazzi Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy Circulation 124 2011 2290 2295
30. D.R. Van Wagoner Colchicine for the prevention of postoperative atrial fibrillation: a new indication for a very old drug? Circulation 124 2011 2281 2282
31. P. Bruins, H. te Velthuis, and A.P. Yazdanbakhsh Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
32. R.H. Abdelhadi, H.S. Gurm, D.R. Van Wagoner, and M.K. Chung Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively Am J Cardiol 93 2004 1176 1178
33. Y. Ishii, R.B. Schuessler, and S.L. Gaynor Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation Circulation 111 2005 2881 2888
34. R.N. Goldstein, K. Ryu, C. Khrestian, D.R. van Wagoner, and A.L. Waldo Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model J Cardiovasc Electrophysiol 19 2008 74 81
35. K.M. Ho, and J.A. Tan Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis Circulation 119 2009 1853 1866
36. S. Deftereos, G. Giannopoulos, and C. Kossyvakis Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study J Am Coll Cardiol 60 2012 1790 1796
37. T. Koyama, Y. Sekiguchi, and H. Tada Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation Am J Cardiol 103 2009 1249 1254
38. J.M. McCabe, L.M. Smith, and Z.H. Tseng Protracted CRP elevation after atrial fibrillation ablation Pacing Clin Electrophysiol 31 2008 1146 1151
39. T. Koyama, H. Tada, and Y. Sekiguchi Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial J Am Coll Cardiol 56 2010 1463 1472
40. N. Sata, N. Hamada, and T. Horinouchi C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 45 2004 441 445
41. K. Friedrichs, A. Klinke, and S. Baldus Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 2011 556 563
42. T. Rostock, D. Steven, and B. Lutomsky Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans J Am Coll Cardiol 51 2008 2153 2160
43. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
44. P. Leong-Sit, J.F. Roux, and E. Zado Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study Circ Arrhythm Electrophysiol 4 2011 11 14
45. A. Kamkin, S. Kirischuk, and I. Kiseleva Single mechano-gated channels activated by mechanical deformation of acutely isolated cardiac fibroblasts from rats Acta Physiol (Oxf) 199 2010 277 292
46. A. Kamkin, I. Kiseleva, and K.D. Wagner Mechanically induced potentials in rat atrial fibroblasts depend on actin and tubulin polymerisation Pflugers Arch 442 2001 487 497
47. D. Malan, M.P. Gallo, I. Bedendi, C. Biasin, R.C. Levi, and G. Alloatti Microtubules mobility affects the modulation of L-type I(Ca) by muscarinic and beta-adrenergic agonists in guinea-pig cardiac myocytes J Mol Cell Cardiol 35 2003 195 206
48. J. Heijman, N. Voigt, S. Nattel, and D. Dobrev Calcium handling and atrial fibrillation Wien Med Wochenschr 162 2012 287 291
49. R. Klingenberg, and T.F. Luscher Inflammation in coronary artery disease and acute myocardial infarction - is the stage set for novel therapies? Curr Pharm Des 18 2012 4358 4369
50. M. Drakopoulou, K. Toutouzas, A. Michelongona, D. Tousoulis, and C. Stefanadis Vulnerable plaque and inflammation: potential clinical strategies Curr Pharm Des 17 2011 4190 4209
51. R. Ross Atherosclerosis is an inflammatory disease Am Heart J 138 1999 S419 S420
52. T. Naruko, M. Ueda, and K. Haze Neutrophil infiltration of culprit lesions in acute coronary syndromes Circulation 106 2002 2894 2900
53. G.J. Blake, and P.M. Ridker Are statins anti-inflammatory? Curr Control Trials Cardiovasc Med 1 2000 161 165
54. S. Devaraj, J. Rogers, and I. Jialal Statins and biomarkers of inflammation Curr Atheroscler Rep 9 2007 33 41
55. A.M. Olsen, E.L. Fosbol, and J. Lindhardsen Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients - a nationwide study PLoS One 8 2013 e54309
56. M. Nidorf, and P.L. Thompson Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease Am J Cardiol 99 2007 805 807
57. S.M. Nidorf, J.W. Eikelboom, C.A. Budgeon, and P.L. Thompson Low-dose colchicine for secondary prevention of cardiovascular disease J Am Coll Cardiol 61 2013 404 410
58. D.B. Crittenden, R.A. Lehmann, and L. Schneck Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout J Rheumatol 39 2012 1458 1464
59. N.C. Raju, Q. Yi, M. Nidorf, N.D. Fagel, R. Hiralal, and J.W. Eikelboom Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial J Thromb Thrombolysis 33 2012 88 94
60. I. Sari, A. Yuksel, and D. Kozaci The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever Inflammation 35 2012 1191 1197
61. A. Bouaziz, N.B. Amor, and G.E. Woodard Tyrosine phosphorylation / dephosphorylation balance is involved in thrombin-evoked microtubular reorganisation in human platelets Thromb Haemost 98 2007 375 384
62. J.M. Sneddon Effect of mitosis inhibitors on blood platelet microtubules and aggregation J Physiol 214 1971 145 158
63. S.G. Chu, R.C. Becker, and P.B. Berger Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis J Thromb Haemost 8 2010 148 156
64. A.Y. Gasparyan, L. Ayvazyan, D.P. Mikhailidis, and G.D. Kitas Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17 2011 47 58
65. N. Kilicli-Camur, R. Demirtunc, C. Konuralp, A. Eskiser, and Y. Basaran Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 11 2005 387 392
66. G.B. Abanonu, A. Daskin, M.F. Akdogan, S. Uyar, and R. Demirtunc Mean platelet volume and beta-thromboglobulin levels in familial Mediterranean fever: effect of colchicine use? Eur J Intern Med 23 2012 661 664
67. E. Coban, and H. Adanir Platelet activation in patients with Familial Mediterranean Fever Platelets 19 2008 405 408
68. S. Arica, C. Ozer, V. Arica, A. Karakus, T. Celik, and R. Gunesacar Evaluation of the mean platelet volume in children with familial Mediterranean fever Rheumatol Int 32 2012 3559 3563
69. B. Makay, Z. Turkyilmaz, and E. Unsal Mean platelet volume in children with familial Mediterranean fever Clin Rheumatol 28 2009 975 978
70. P. Libby, D. Schwartz, E. Brogi, H. Tanaka, and S.K. Clinton A cascade model for restenosis. A special case of atherosclerosis progression Circulation 86 1992 47 52
71. H.M. Atta, M.A. El-Rehany, S.R. Abdel Raheim, R. Fouad, and A.M. Galal Colchicine inhibits intimal hyperplasia and leukocyte VEGF expression in dogs J Surg Res 146 2008 184 189
72. J.H. O'Keefe Jr., B.D. McCallister, T.M. Bateman, D.L. Kuhnlein, R.W. Ligon, and G.O. Hartzler Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty J Am Coll Cardiol 19 1992 1597 1600
73. M. Freed, R.D. Safian, W.W. O'Neill, M. Safian, D. Jones, and C.L. Grines Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol 76 1995 1185 1188
74. C.L. Grines, D.A. Cox, and G.W. Stone Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 341 1999 1949 1956
75. G.W. Stone, A.J. Lansky, and S.J. Pocock Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
76. S. Deftereos, G. Giannopoulos, and K. Raisakis Colchicine treatment for prevention of bare-metal stent restenosis in diabetics J Am Coll Cardiol 61 2013 1679 1685
77. R. Hoffmann, and G.S. Mintz Coronary in-stent restenosis - predictors, treatment and prevention Eur Heart J 21 2000 1739 1749
78. R. Hoffmann, G.S. Mintz, and G.R. Dussaillant Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study Circulation 94 1996 1247 1254
79. G.S. Mintz, J.J. Popma, and A.D. Pichard Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study Circulation 94 1996 35 43
80. M. Koide, M. Hamawaki, and T. Narishige Microtubule depolymerization normalizes in vivo myocardial contractile function in dogs with pressure-overload left ventricular hypertrophy Circulation 102 2000 1045 1052
81. B.S. Scopacasa, V.P. Teixeira, and K.G. Franchini Colchicine attenuates left ventricular hypertrophy but preserves cardiac function of aortic-constricted rats J Appl Physiol 94 2003 1627 1633
82. H. Tsutsui, Y. Ishibashi, and M. Takahashi Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats J Mol Cell Cardiol 31 1999 1203 1213
83. H.E. ter Keurs Microtubules in cardiac hypertrophy: a mechanical role in decompensation? Circ Res 82 1998 828 831
84. G. Cheng, M.R. Zile, and M. Takahashi A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart Am J Physiol Heart Circ Physiol 294 2008 H2231 H2241
85. S. Yamamoto, H. Tsutsui, and M. Takahashi Role of microtubules in the viscoelastic properties of isolated cardiac muscle J Mol Cell Cardiol 30 1998 1841 1853
86. S. Nishimura, S. Nagai, and M. Katoh Microtubules modulate the stiffness of cardiomyocytes against shear stress Circ Res 98 2006 81 87
87. A.M. Gomez, B.G. Kerfant, and G. Vassort Microtubule disruption modulates Ca(2+) signaling in rat cardiac myocytes Circ Res 86 2000 30 36
88. B.G. Kerfant, G. Vassort, and A.M. Gomez Microtubule disruption by colchicine reversibly enhances calcium signaling in intact rat cardiac myocytes Circ Res 88 2001 E59 E65